Abstract
OR23-05 Log-term Efficacy And Safety Of Transcon PTH In Adults With Hypoparathyroidism: 52-week Results From The Open-label Extension Of The Phase 3 Pathway Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have